Wall Street Analysts Believe Keros Therapeutics (KROS) Could Rally 153.67%: Here's is How to Trade

Core Viewpoint - Keros Therapeutics, Inc. (KROS) shows significant upside potential with a mean price target of $29.40, indicating a 153.7% increase from its current price of $11.59 [1] Price Targets - The average price target consists of 10 estimates ranging from a low of $15 to a high of $43, with a standard deviation of $10.46, suggesting variability in analyst predictions [2] - The lowest estimate indicates a 29.4% increase, while the highest suggests a 271% upside [2] - A low standard deviation indicates a strong agreement among analysts regarding the stock's price movement [7] Analyst Sentiment - Analysts exhibit growing optimism about KROS's earnings prospects, as evidenced by a positive trend in earnings estimate revisions, which correlates with potential stock price increases [9] - Over the past 30 days, six earnings estimates have been revised upward, leading to a 7.5% increase in the Zacks Consensus Estimate [10] Zacks Rank - KROS holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimate factors, indicating strong potential for upside [11] Conclusion on Price Targets - While consensus price targets may not reliably predict the extent of KROS's gains, they can provide a directional guide for potential price movements [12]